Antibody · 고형암 (전체)

249개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved249 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleInstitut BergoniéPhase 2

durvalumab (Imfinzi, Association of lurbinectedin and durvalumab)

Small Cell Lung Cancer; Platinum-Sensitive Lung Small Cell Carcinoma · Small Cell Lung Cancer

#SmallCellLungCancer#Antibody#Phase2#monoclonal-antibody#Platinum-SensitiveLungSmallCellC+1
Trials 1Status Discontinued
AntibodyLimited DatastaleRochePhase 2

adjuvant (Atezolizumab, Atezolizumab (adjuvant))

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

neoadjuvant (Atezolizumab, Atezolizumab (neoadjuvant))

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab + Ipatasertib)

Gastric Adenocarcinoma; Metastatic Gastric Cancer · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase2#monoclonal-antibody#MetastaticGastricCancer+1
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab combined with bevacizumab combined with β- alanine)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab, 6-mercaptopurine, 6-thioguanine)

Solid Tumor, Adult; Metastatic Cancer · Solid Tumor, Adult

#SolidTumorAdult#Antibody#Phase2#monoclonal-antibody#SolidTumor+3
Trials 1Status Active
AntibodyLimited DatastaleSyndax PharmaceuticalsPhase 1

Axatilimab (Axatilimab)

Solid Tumor; Metastatic Tumor · Solid Tumor

#SolidTumor#Antibody#Phase1#monoclonal-antibody#MetastaticTumor+1
Trials 1Status Active
AntibodyLimited DatastaleNavire Pharma Inc., a BridgeBio…Phase 1

nivolumab (Opdivo, BBP-398 with nivolumab)

Non Small Cell Lung Cancer; Solid Tumor · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase1#monoclonal-antibody#SolidTumor+1
Trials 1Status Discontinued
AntibodyLimited DatastaleByondis B.V.Phase 1

pembrolizumab (Keytruda, BYON4228 + Pembrolizumab)

Solid Tumor · Solid Tumor

#SolidTumor#Antibody#Phase1#monoclonal-antibody#Byondis
Trials 1Status Recruiting
AntibodyLimited DatastaleYuan YuanPhase 2

Balstilmab (Balstilmab)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Triple-Negative Breast Carcinoma · Anatomic Stage IV Breast Cancer AJCC v8

#AnatomicStageIVBreastCancerAJCCv#Antibody#Phase2#monoclonal-antibody#MetastaticTriple-NegativeBreastC+1
Trials 1Status Recruiting
AntibodyLimited DatastaleBayerPhase 1

BAY1905254 (Bapotulimab, Bapotulimab (BAY1905254))

Advanced Solid Tumor; Head and Neck Squamous Cell Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#monoclonal-antibody#HeadandNeckSquamousCellCarcinoma+1
Trials 1Status Active
AntibodyLimited DatastaleMerckPhase 1

pembrolizumab (Keytruda, BAY1905254, Bapotulimab, Bapotulimab (BAY1905254) + Pembrolizumab (KEYTRUDA®))

Advanced Solid Tumor; Head and Neck Squamous Cell Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#monoclonal-antibody#HeadandNeckSquamousCellCarcinoma+1
Trials 1Status Active
AntibodyLimited DatastaleSun Yat-sen UniversityPhase 2

cetuximab (C225, C225 (cetuximab))

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#monoclonal-antibody#Sun
Trials 1Status Active
AntibodyLimited DatastaleTae Won KimPhase 2

durvalumab (Imfinzi, CKD-516 plus Durvalumab)

Colorectal Cancer; Solid Tumor · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#SolidTumor+1
Trials 1Status Discontinued
AntibodyLimited DatastaleTaizhou Mabtech Pharmaceutical …Phase 1

CMAB819 (CMAB819)

Squamous Cell Carcinoma of the Head and Neck · Squamous Cell Carcinoma of the Head and

#SquamousCellCarcinomaoftheHeadan#Antibody#Phase1#monoclonal-antibody#Taizhou
Trials 1Status Discontinued
AntibodyLimited DatastaleCompugen LtdPhase 1

nivolumab (Opdivo, COM701 with Opdivo, COM701 with Opdivo (Nivolumab).)

Advanced Cancer; Ovarian Cancer · Advanced Cancer

#AdvancedCancer#Antibody#Phase1#monoclonal-antibody#OvarianCancer+1
Trials 1Status Active
AntibodyLimited DatastaleShen FengPhase 2

Cadonilimab+Gem/Cis (Cadonilimab+Gem/Cis)

Intrahepatic Cholangiocarcinoma · Intrahepatic Cholangiocarcinoma

#IntrahepaticCholangiocarcinoma#Antibody#Phase2#monoclonal-antibody#Shen
Trials 1Status Active
AntibodyLimited DatastaleJiangsu HengruiPhase 3

Camrelizumab and Cetuximab (Camrelizumab and Cetuximab)

Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase3#monoclonal-antibody#Jiangsu
Trials 1Status Recruiting
AntibodyLimited DatastaleJiangsu HengruiPhase 3

Camrelizumab and Chemotherapy (Camrelizumab and Chemotherapy)

Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase3#monoclonal-antibody#Jiangsu
Trials 1Status Recruiting
AntibodyLimited DatastaleJiangsu HengruiPhase 2

Camrelizumab+cetuximab+chemotherapy (Camrelizumab+cetuximab+chemotherapy)

Squamous Cell Carcinoma of Head and Neck · Squamous Cell Carcinoma of Head and Neck

#SquamousCellCarcinomaofHeadandNe#Antibody#Phase2#monoclonal-antibody#Jiangsu
Trials 1Status Active

6 / 13 pages

← PreviousNext →